fixed drug eruption
Jump to navigation
Jump to search
Introduction
Red to red-brown macules that appear on a certain area of the patient's skin secondary to a drug.
Etiology
- antibiotics, especially sulfonamides most commonly implicated
- phenolphthalein
- barbiturates
- NSAIDs, salicylates
- oral contraceptives
- pseudoephedrine
Pathology
Clinical manifestations
- red to red-brown macules localized to a certain area
- can be anywhere on the body
- most commonly characterized by a solitary, round to oval violaceous patch on the skin or mucosa[4]
- multiple patches may rarely occur[4]
- patches sharply demarcated
- no pruritus
- occasional fever
- resolution often with postinflammatory hyperpigmentation
- if offending agent is administered again, rash will often recur at the same localization[4]
- re-exposure may result in new lesion(s) in addition to the original lesion[2]
* images[5]
Management
- discontinuation of offending agent
- reassurance: cosmetic only, no serious sequelae
- lesions resolve over days to weeks
More general terms
References
- ↑ Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 30-31, 170
- ↑ 2.0 2.1 2.2 2.3 2.4 Medical Knowledge Self Assessment Program (MKSAP) 17, American College of Physicians, Philadelphia 2015
- ↑ 3.0 3.1 3.2 Mizukawa Y, Shiohara T Fixed drug eruption: a prototypic disorder mediated by effector memory T cells. Curr Allergy Asthma Rep. 2009 Jan;9(1):71-7 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19063828
- ↑ 4.0 4.1 4.2 4.3 NEJM Knowledge+ Question of the Week. Nov 8, 2016 http://knowledgeplus.nejm.org/question-of-week/1452/
- ↑ 5.0 5.1 Elston CA, Elston DM Identifying Lesions on Skin of Color. Medscape. October 25, 2022 https://reference.medscape.com/slideshow/identifying-lesions-6007985